Trials / Completed
CompletedNCT03359551
Natural History of the Progression of Choroideremia Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 319 (actual)
- Sponsor
- NightstaRx Ltd, a Biogen Company · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this natural history study is to gain a better understanding of the progression of choroideremia (CHM) and add to the knowledge base for this rare disease.
Detailed description
This study was previously posted by NightstaRx Ltd. In October 2020, sponsorship of the trial was transferred to Biogen.
Conditions
Timeline
- Start date
- 2015-06-30
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2017-12-02
- Last updated
- 2023-02-10
Locations
20 sites across 9 countries: United States, Brazil, Canada, Denmark, Finland, France, Germany, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT03359551. Inclusion in this directory is not an endorsement.